MVA-HPV-IL2: Phase II data

In an open-label, single-arm, French Phase II study in 21 women, TG4001 met the primary endpoint. Specifically, about 9 of 18 women had no CIN 2/3 at 6 months. Also, 10 women had normal colposcopy and...